Merck & Co., Inc. Vaccine Wins OK for Vaginal Cancer

WASHINGTON (Reuters) - U.S. health regulators have approved Merck and Co's Gardasil vaccine to protect women against rare vaginal and vulvar cancers, the Food and Drug Administration said on Friday.